These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 27590274)
1. Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients. Medrano LM; Rallón N; Berenguer J; Jiménez-Sousa MA; Soriano V; Aldámiz-Echevarria T; Fernández-Rodríguez A; García M; Tejerina F; Martínez I; Benito JM; Resino S J Transl Med; 2016 Sep; 14(1):257. PubMed ID: 27590274 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of TRIM5 and TRIM22 polymorphisms on treatment responses in Iranian patients with chronic hepatitis C virus infection. Mobasheri S; Irani N; Sepahi AA; Sakhaee F; Jamnani FR; Vaziri F; Siadat SD; Fateh A Gene; 2018 Nov; 676():95-100. PubMed ID: 30017737 [TBL] [Abstract][Full Text] [Related]
3. IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection. Jiménez-Sousa MA; Berenguer J; Rallón N; Pineda-Tenor D; Aldamiz-Echevarria T; Soriano V; García-Álvarez M; Vazquez-Morón S; Restrepo C; Carrero A; Benito JM; Resino S Liver Int; 2016 Sep; 36(9):1258-66. PubMed ID: 26836972 [TBL] [Abstract][Full Text] [Related]
4. FTO rs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients. Pineda-Tenor D; Berenguer J; Jiménez-Sousa MA; García-Alvarez M; Aldámiz-Echevarria T; Carrero A; Vázquez-Morón S; García-Broncano P; Diez C; Tejerina F; Guzmán-Fulgencio M; Resino S BMC Med; 2014 Nov; 12():198. PubMed ID: 25367448 [TBL] [Abstract][Full Text] [Related]
5. Liver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV/HCV coinfected patients. Corchado S; López-Cortés LF; Rivero-Juárez A; Torres-Cornejo A; Rivero A; Márquez-Coello M; Girón-González JA PLoS One; 2014; 9(7):e101760. PubMed ID: 25013899 [TBL] [Abstract][Full Text] [Related]
6. TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients. Jiménez-Sousa MA; Rallón N; Berenguer J; Pineda-Tenor D; López JC; Soriano V; Guzmán-Fulgencio M; Cosín J; Retana D; García-Álvarez M; Miralles P; Benito JM; Resino S J Clin Virol; 2015 Apr; 65():62-7. PubMed ID: 25766991 [TBL] [Abstract][Full Text] [Related]
7. Association between IL7RA polymorphisms and the successful therapy against HCV in HIV/HCV-coinfected patients. Guzmán-Fulgencio M; Berenguer J; Pineda-Tenor D; Jiménez-Sousa MA; García-Álvarez M; Aldámiz-Echevarria T; Carrero A; Diez C; Tejerina F; Vázquez S; Briz V; Resino S Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):385-93. PubMed ID: 25236396 [TBL] [Abstract][Full Text] [Related]
8. Association between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional study. Guzmán-Fulgencio M; Berenguer J; Jiménez-Sousa MA; Pineda-Tenor D; Aldámiz-Echevarria T; García-Broncano P; Carrero A; García-Álvarez M; Tejerina F; Diez C; Vazquez-Morón S; Resino S J Transl Med; 2015 Jun; 13():206. PubMed ID: 26123260 [TBL] [Abstract][Full Text] [Related]
9. CXCL9, CXCL10 and CXCL11 polymorphisms are associated with sustained virologic response in HIV/HCV-coinfected patients. Pineda-Tenor D; Berenguer J; Jiménez-Sousa MA; Guzmán-Fulgencio M; Aldámiz-Echevarria T; Carrero A; García-Álvarez M; Diez C; Tejerina F; Briz V; Resino S J Clin Virol; 2014 Nov; 61(3):423-9. PubMed ID: 25218243 [TBL] [Abstract][Full Text] [Related]
10. IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin. Rallón NI; Soriano V; Naggie S; Restrepo C; Goldstein D; Vispo E; McHutchison J; Benito JM AIDS; 2011 May; 25(8):1025-33. PubMed ID: 21505315 [TBL] [Abstract][Full Text] [Related]
12. PPARγ2 Pro12Ala polymorphism is associated with sustained virological response in HIV/HCV-coinfected patients under HCV therapy. Fernández-Rodríguez A; Berenguer J; Rallón N; Jiménez-Sousa MA; López JC; Soriano V; García-Álvarez M; Cosín J; Martínez P; Guzmán-Fulgencio M; Miralles P; Miguel Benito J; Resino S J Acquir Immune Defic Syndr; 2014 Oct; 67(2):113-9. PubMed ID: 25072612 [TBL] [Abstract][Full Text] [Related]
13. Short Communication: CXCL12 rs1029153 Polymorphism Is Associated with the Sustained Virological Response in HIV/Hepatitis C Virus-Coinfected Patients on Hepatitis C Virus Therapy. Pineda-Tenor D; Jiménez-Sousa MA; Rallón N; Berenguer J; Soriano V; Aldámiz-Echevarria T; García-Álvarez M; Diez C; Fernández-Rodríguez A; Benito JM; Resino S AIDS Res Hum Retroviruses; 2016 Mar; 32(3):226-31. PubMed ID: 26499461 [TBL] [Abstract][Full Text] [Related]
14. HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy. Guzmán-Fulgencio M; Berenguer J; Rallón N; Fernández-Rodríguez A; Miralles P; Soriano V; Jiménez-Sousa MA; Cosín J; Medrano J; García-Álvarez M; López JC; Benito JM; Resino S AIDS; 2013 May; 27(8):1231-8. PubMed ID: 23811951 [TBL] [Abstract][Full Text] [Related]
15. Increased expression and dysregulated association of restriction factors and type I interferon in HIV, HCV mono- and co-infected patients. Zhu JW; Liu FL; Mu D; Deng DY; Zheng YT J Med Virol; 2016 Jun; 88(6):987-95. PubMed ID: 26519943 [TBL] [Abstract][Full Text] [Related]
16. On the relationship between tripartite motif-containing 22 single-nucleotide polymorphisms and COVID-19 infection severity. Raheem Juhi Al-Kaabi N; Khameneh SC; Montazeri M; Mardasi M; Amroabadi JM; Sakhaee F; Fateh A Hum Genomics; 2022 Aug; 16(1):33. PubMed ID: 36028902 [TBL] [Abstract][Full Text] [Related]
17. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C. Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692 [TBL] [Abstract][Full Text] [Related]
18. Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study. Kovari H; Russmann S; Ledergerber B; Müller D; Rotger M; Velli P; Cavassini M; Ambrosioni J; Bregenzer A; Stöckle M; Bernasconi E; Rauch A; Speck RF; PLoS One; 2015; 10(7):e0133879. PubMed ID: 26218843 [TBL] [Abstract][Full Text] [Related]
19. Genetic variants upstream of TNFAIP3 in the 6q23 region are associated with liver disease severity in HIV/HCV-coinfected patients: A cross-sectional study. Jiménez-Sousa MA; Berenguer J; Fernández-Rodríguez A; Medrano LM; Aldámiz-Echevarria T; Pérez-Latorre L; Díez C; Martín-Vicente M; Gutiérrez-Rivas M; Martínez I; Resino S Infect Genet Evol; 2019 Jan; 67():112-120. PubMed ID: 30336268 [TBL] [Abstract][Full Text] [Related]
20. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy. Barreiro P; Pineda JA; Rallón N; Naggie S; Martín-Carbonero L; Neukam K; Rivero A; Benito JM; Caruz A; Vispo E; Camacho A; Medrano J; McHutchison J; Soriano V J Infect Dis; 2011 Jun; 203(11):1629-36. PubMed ID: 21592993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]